The Okyanos treatment protocol is based upon the PRECISE trial, which demonstrated statistically significant improvements in:
There were no liposuction or ADRCAdipose derived stem and regenerative cells injection-related MACCE (Major Adverse Cardiac and Cerebrovascular events) at either 6 or 18 months.
The PRECISE trial using stem cells for heart disease treatment was a multi-center, double-blinded placebo control study for end-stage patients with coronary artery diseaseHeart disease caused by plaque having built up in the arteries..
Adipose-Derived Regenerative Cells Improve Cardiac Functional Capacity at 18 Months in Chronic Ischemic Heart Disease Patients; Statistically Significant Improvement in MVO2 Reported at American Heart Association (2010, November 15) in Marketwire. Retrieved March 9, 2012, from http://www.marketwire.com/press-release/Adipose-Derived-Regenerative-Cells-Improve-Cardiac-Functional-Capacity-18-Months-Chronic-NASDAQ-CYTX-1353581.htm.